Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia

Clinical trial NCT00607919 · COMPLETED

Trial details

NCT number: NCT00607919
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder Dyslexia

Start date: 2008-03-01
Primary completion: 2010-11-01
Enrollment: 209

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.